多发性内分泌肿瘤 2B 型的临床试验
总计58951个结果
-
Allogene Therapeutics主动,不招人
-
iOMEDICO AGAmgen主动,不招人
-
Acerta Pharma BVAcerta Pharma, LLC完全的
-
Chong Kun Dang Pharmaceutical未知
-
AEterna Zentaris完全的多发性骨髓瘤 | 多发性骨髓瘤复发
-
National Cancer Institute (NCI)完全的
-
Dana-Farber Cancer InstituteBristol-Myers Squibb尚未招聘
-
Andrew Yee, MDJanssen Research & Development, LLC; Amgen招聘中
-
Pfizer主动,不招人多发性骨髓瘤 | 难治性多发性骨髓瘤 | 骨髓瘤 | 复发性多发性骨髓瘤 | 埃拉那他单抗 | PF-06863135 | BCMA | 双特异性 | 双特异性抗体 | BCMA-CD3双特异性 | 磁铁MM-8中国
-
Alfred Chung, MDMerck Sharp & Dohme LLC终止
-
Academisch Medisch Centrum - Universiteit van Amsterdam...VU University of Amsterdam招聘中
-
Cambridge University Hospitals NHS Foundation TrustThe Gurdon Institute; Ann McLaren Laboratory of Regenerative Medicine未知
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical University招聘中
-
Universitätsklinikum Hamburg-Eppendorf招聘中
-
Chunrui LiInnovent Biologics (Suzhou) Co. Ltd.招聘中
-
Assiut University尚未招聘Multiple Myeloma Survival Outcome
-
PETHEMA FoundationAdknoma Health Research招聘中
-
Pack HealthM.D. Anderson Cancer Center; Sanofi; University of Washington招聘中
-
BeiGene招聘中复发/难治性多发性骨髓瘤美国, 中国, 澳大利亚, 大韩民国, 加拿大, 英国, 以色列, 新加坡, 新西兰, 巴西
-
Zhejiang UniversityYake Biotechnology Ltd.尚未招聘
-
University of ChicagoNational Cancer Institute (NCI)招聘中
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.; Hartford Hospital完全的
-
Washington University School of MedicineBristol-Myers Squibb; Celgene主动,不招人
-
Allogene Therapeutics主动,不招人
-
Multiple Myeloma Research ConsortiumBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center; Washington University School of... 和其他合作者主动,不招人
-
Al-Rasheed University CollegeBaghdad Medical City撤销
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb终止
-
Hackensack Meridian HealthMerck Sharp & Dohme LLC撤销